Cargando…

BTK Inhibitors Impair Platelet-Mediated Antifungal Activity

In recent years, the introduction of new drugs targeting Bruton’s tyrosine kinase (BTK) has allowed dramatic improvement in the prognosis of patients with chronic lymphocytic leukemia (CLL) and other B-cell neoplasms. Although these small molecules were initially considered less immunosuppressive th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasillo, Vincenzo, Lagreca, Ivana, Vallerini, Daniela, Barozzi, Patrizia, Riva, Giovanni, Maccaferri, Monica, Paolini, Ambra, Forghieri, Fabio, Fiorcari, Stefania, Maffei, Rossana, Martinelli, Silvia, Atene, Claudio Giacinto, Castelli, Ilaria, Marasca, Roberto, Potenza, Leonardo, Comoli, Patrizia, Manfredini, Rossella, Tagliafico, Enrico, Trenti, Tommaso, Luppi, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947638/ https://www.ncbi.nlm.nih.gov/pubmed/35326454 http://dx.doi.org/10.3390/cells11061003

Ejemplares similares

The dynamic functions of IRF4 in B cell malignancies
por: Maffei, Rossana, et al.
Publicado: (2022)

Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges
por: Riva, Giovanni, et al.
Publicado: (2021)

BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia
por: Fiorcari, Stefania, et al.
Publicado: (2020)

Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies
por: Nasillo, Vincenzo, et al.
Publicado: (2021)

The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches
por: Lagreca, Ivana, et al.
Publicado: (2022)

NPM1-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
por: Forghieri, Fabio, et al.
Publicado: (2020)

Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia
por: Forghieri, Fabio, et al.
Publicado: (2021)

Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies
por: Lagreca, Ivana, et al.
Publicado: (2023)

Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1
por: Fiorcari, Stefania, et al.
Publicado: (2022)

Nurse-Like Cells and Chronic Lymphocytic Leukemia B Cells: A Mutualistic Crosstalk inside Tissue Microenvironments
por: Fiorcari, Stefania, et al.
Publicado: (2021)

COVID-19: more than a cytokine storm
por: Riva, Giovanni, et al.
Publicado: (2020)

Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia
por: Forghieri, Fabio, et al.
Publicado: (2019)

Acute Myeloid Leukemia in Patients Living with HIV Infection: Several Questions, Fewer Answers
por: Forghieri, Fabio, et al.
Publicado: (2020)

Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection
por: Fiorcari, Stefania, et al.
Publicado: (2021)

Role of Notch2 pathway in mature B cell malignancies
por: Mesini, Nicolò, et al.
Publicado: (2023)

Pathogenetic Mechanisms of Hepatitis C Virus-Induced B-Cell Lymphomagenesis
por: Forghieri, Fabio, et al.
Publicado: (2012)

Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation
por: Atene, Claudio Giacinto, et al.
Publicado: (2022)

How to Improve Prognostication in Acute Myeloid Leukemia with CBFB-MYH11 Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) Monitoring
por: Talami, Annalisa, et al.
Publicado: (2021)

All‐trans retinoic acid (ATRA) in non‐promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low‐dose Ara‐C in three elderly patients with NPM1‐mutated AML unfit for intensive chemotherapy and review of the literature
por: Forghieri, Fabio, et al.
Publicado: (2016)

Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives
por: Forghieri, Fabio, et al.
Publicado: (2018)

Effects of the BTN162b2 mRNA COVID‐19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia
por: Fiorcari, Stefania, et al.
Publicado: (2022)

BCR–ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy
por: Riva, G, et al.
Publicado: (2011)

Adverse outcome associated with daratumumab-based treatments in relapsed/refractory multiple myeloma patients with amplification of chromosome arm 1q21: a single-center retrospective experience
por: Barbieri, Emiliano, et al.
Publicado: (2022)

Mucorales-Specific T Cells in Patients with Hematologic Malignancies
por: Potenza, Leonardo, et al.
Publicado: (2016)

Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib
por: Maffei, Rossana, et al.
Publicado: (2015)

β-HHVs and HHV-8 in Lymphoproliferative Disorders
por: Quadrelli, C., et al.
Publicado: (2011)

COVID-19: room for treating T cell exhaustion?
por: Riva, Giovanni, et al.
Publicado: (2020)

Linking COVID-19, monocyte activation and sepsis: MDW, a novel biomarker from cytometry
por: Riva, Giovanni, et al.
Publicado: (2021)

Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1(mut)) for the Treatment of NPM1(mut)-Acute Myeloid Leukemia
por: De Cicco, Marica, et al.
Publicado: (2023)

An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1–MECOM fusion transcripts
por: Forghieri, Fabio, et al.
Publicado: (2014)

Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia
por: Maffei, Rossana, et al.
Publicado: (2017)

Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia
por: Fiorcari, Stefania, et al.
Publicado: (2016)

Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients
por: Riva, Giovanni, et al.
Publicado: (2021)

Endothelin-1 Promotes Survival and Chemoresistance in Chronic Lymphocytic Leukemia B Cells through ET(A) Receptor
por: Maffei, Rossana, et al.
Publicado: (2014)

Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients
por: Potenza, Leonardo, et al.
Publicado: (2013)

COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit
por: Gilioli, Andrea, et al.
Publicado: (2023)

Parvoviruses in Blood Donors and Transplant Patients, Italy
por: Vallerini, Daniela, et al.
Publicado: (2008)

Severe Pneumonia Caused by Legionella pneumophila Serogroup 11, Italy
por: Grottola, Antonella, et al.
Publicado: (2012)

iVar, an Interpretation-Oriented Tool to Manage the Update and Revision of Variant Annotation and Classification
por: Castellano, Sara, et al.
Publicado: (2021)

An 81-Year-Old Man with a 6-Year History of Chronic Lymphocytic Leukemia Presenting with Disease Flare Following Ibrutinib Discontinuation
por: Pozzi, Stefano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q22m7gvq7ge6glkh08ll0ouk6r